S. Pecorelli

11.2k total citations · 2 hit papers
97 papers, 6.8k citations indexed

About

S. Pecorelli is a scholar working on Reproductive Medicine, Obstetrics and Gynecology and Oncology. According to data from OpenAlex, S. Pecorelli has authored 97 papers receiving a total of 6.8k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Reproductive Medicine, 25 papers in Obstetrics and Gynecology and 17 papers in Oncology. Recurrent topics in S. Pecorelli's work include Ovarian cancer diagnosis and treatment (45 papers), Endometrial and Cervical Cancer Treatments (23 papers) and Cervical Cancer and HPV Research (11 papers). S. Pecorelli is often cited by papers focused on Ovarian cancer diagnosis and treatment (45 papers), Endometrial and Cervical Cancer Treatments (23 papers) and Cervical Cancer and HPV Research (11 papers). S. Pecorelli collaborates with scholars based in Italy, Belgium and United States. S. Pecorelli's co-authors include G. Favalli, J. Renard, M. van Lent, Ángel J. Lacave, Marc Buyse, Ignace Vergote, Nicoletta Colombo, J.L. Benedet, Massimo Piergiuseppe Franchi and Giorgio Bolis and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Journal of Clinical Oncology.

In The Last Decade

S. Pecorelli

96 papers receiving 6.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium

2009 2.1k citations S. Pecorelli profile →
The Effect of Debulking Surgery after Induction Chemotherapy on the Prognosis in Advanced Epithelial Ovarian Cancer

1995 484 citations M. van Lent, Marc Buyse et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
S. Pecorelli Italy	34	3.5k	3.5k	1.8k	1.3k	1.2k	97	6.8k
William M. Burke United States	49	4.2k 1.2×	3.1k 0.9×	2.0k 1.1×	1.3k 1.0×	1.0k 0.8×	201	7.5k
Ludovico Muzii Italy	49	3.9k 1.1×	4.2k 1.2×	2.4k 1.3×	981 0.8×	818 0.7×	352	7.9k
Laura J. Havrilesky United States	47	3.3k 0.9×	3.5k 1.0×	1.3k 0.7×	2.1k 1.7×	1.0k 0.8×	301	8.0k
Roberto Angioli Italy	42	3.0k 0.8×	2.8k 0.8×	2.3k 1.3×	1.1k 0.9×	747 0.6×	286	6.3k
Amanda N. Fader United States	49	4.2k 1.2×	3.0k 0.9×	2.3k 1.2×	1.6k 1.2×	723 0.6×	222	7.3k
Gavin Stuart Canada	36	2.1k 0.6×	3.7k 1.1×	2.6k 1.4×	1.6k 1.3×	1.1k 0.9×	118	6.1k
Christina Fotopoulou United Kingdom	39	2.4k 0.7×	3.4k 1.0×	1.8k 1.0×	1.4k 1.2×	543 0.5×	246	6.5k
Laurel W. Rice United States	38	2.1k 0.6×	1.9k 0.6×	1.0k 0.6×	895 0.7×	827 0.7×	122	4.5k
Vito Chiàntera Italy	41	3.8k 1.1×	3.6k 1.0×	1.9k 1.0×	947 0.8×	812 0.7×	323	6.1k
Barbara A. Goff United States	57	3.4k 1.0×	5.4k 1.6×	2.6k 1.4×	2.4k 1.9×	917 0.8×	231	10.2k

Countries citing papers authored by S. Pecorelli

Since Specialization

Citations

This map shows the geographic impact of S. Pecorelli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Pecorelli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Pecorelli more than expected).

Fields of papers citing papers by S. Pecorelli

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Pecorelli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Pecorelli. The network helps show where S. Pecorelli may publish in the future.

Co-authorship network of co-authors of S. Pecorelli

This figure shows the co-authorship network connecting the top 25 collaborators of S. Pecorelli. A scholar is included among the top collaborators of S. Pecorelli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Pecorelli. S. Pecorelli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Pani, Luca, S. Pecorelli, Giuseppe Rosano, et al.. (2015). Steps Forward in Regulatory Pathways for Acute and Chronic Heart failure. European Journal of Heart Failure. 17(1). 3–8. 7 indexed citations

Bernabei, Roberto, Ubaldo Bonuccelli, Stefania Maggi, et al.. (2014). Hearing loss and cognitive decline in older adults: questions and answers. Aging Clinical and Experimental Research. 26(6). 567–573. 54 indexed citations

Marengoni, Alessandra & S. Pecorelli. (2013). Mental health and the global agenda.. New England Journal of Medicine. 369(14). 1380. 7 indexed citations

Bellone, Stefania, Dana M. Roque, Emiliano Cocco, et al.. (2012). Downregulation of membrane complement inhibitors CD55 and CD59 by siRNA sensitises uterine serous carcinoma overexpressing Her2/neu to complement and antibody-dependent cell cytotoxicity in vitro: implications for trastuzumab-based immunotherapy. British Journal of Cancer. 106(9). 1543–1550. 45 indexed citations

Quinn, Michael, Jacobus Pfisterer, Michael A. Bookman, et al.. (2005). Integration of new or experimental treatment options and new approaches to clinical trials. Annals of Oncology. 16. viii30–viii35. 2 indexed citations

Birgegård, Gunnar, Matti Aapro, Carsten Bokemeyer, et al.. (2005). Cancer-Related Anemia: Pathogenesis, Prevalence and Treatment. Oncology. 68(Suppl. 1). 3–11. 164 indexed citations

Colombo, Nicoletta & S. Pecorelli. (2003). What have we learned from ICON1 and ACTION?. International Journal of Gynecological Cancer. 13(s2). 140–143. 20 indexed citations

Colombo, Nicoletta & S. Pecorelli. (2003). What have we learned from ICON1 and ACTION?. International Journal of Gynecological Cancer. 13. 140–143. 15 indexed citations

Pecorelli, S.. (2002). The Italian gynecological consensus statement on the use of epoetin alfa in the management of anemia. Seminars in Oncology. 29(3 Suppl 8). 13–15. 2 indexed citations

10.

Wagenaar, Hendrik, N. Colombo, Ignace Vergote, et al.. (2001). Bleomycin, Methotrexate, and CCNU in Locally Advanced or Recurrent, Inoperable, Squamous-Cell Carcinoma of the Vulva: An EORTC Gynaecological Cancer Cooperative Group Study. Gynecologic Oncology. 81(3). 348–354. 57 indexed citations

11.

Piccart, Martine, Andreas du Bois, M. Gore, et al.. (2000). A new standard of care for treatment of ovarian cancer. European Journal of Cancer. 36(1). 10–12. 24 indexed citations

12.

Pawinski, Adam, et al.. (1999). Cyclophosphamide or ifosfamide in patients with advanced and/or recurrent endometrial carcinoma: a randomized phase II study of the EORTC Gynecological Cancer Cooperative Group. European Journal of Obstetrics & Gynecology and Reproductive Biology. 86(2). 179–183. 31 indexed citations

13.

Rc, Young & S. Pecorelli. (1998). Management of early ovarian cancer.. PubMed. 25(3). 335–9. 21 indexed citations

14.

Santin, Alessandro D., Paul L. Hermonat, John C. Hiserodt, et al.. (1997). Effects of irradiation on the expression of major histocompatibility complex class I antigen and adhesion costimulation molecules ICAM-1 in human cervical cancer. International Journal of Radiation Oncology*Biology*Physics. 39(3). 737–742. 55 indexed citations

15.

Wengler, Georg S., Arnalda Lanfranchi, T. Frusca, et al.. (1996). In-utero transplantation of parental CD34 haematopoietic progenitor cells in a patient with X-linked severe combined immunodeficiency (SCIDX1). The Lancet. 348(9040). 1484–1487. 187 indexed citations

16.

Lent, M. van, Marc Buyse, A Kobierska, et al.. (1995). The Effect of Debulking Surgery after Induction Chemotherapy on the Prognosis in Advanced Epithelial Ovarian Cancer. New England Journal of Medicine. 332(10). 629–634. 484 indexed citations breakdown →

17.

Mangioni, C., Giorgio Bolis, S. Pecorelli, et al.. (1989). Randomized Trial in Advanced Ovarian Cancer Comparing Cisplatin and Carboplatin. JNCI Journal of the National Cancer Institute. 81(19). 1464–1471. 110 indexed citations

18.

Colombo, N., C. Sessa, Fabio Landoni, et al.. (1986). Cisplatin, Vinblastine, and Bleomycin Combination Chemotherapy in Metastatic Granulosa Cell Tumor of the Ovary. Obstetrics and Gynecology. 67(2). 265–268. 82 indexed citations

19.

Colombo, Nicoletta, Enrico Sartori, Fabio Landoni, et al.. (1986). Phase II study of the platinum analog TNO-6 in patients with advanced ovarian cancer.. PubMed. 70(6). 793–4. 3 indexed citations

20.

Mangioni, C., et al.. (1985). Vincristine, bleomycin, mitomycin C, cisplatin combination chemotherapy as additive treatment to radiotherapy in poor risk patients with squamous cell carcinoma of the uterine cervix.. PubMed. 201. 225–37. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact